Vasostrict
These highlights do not include all the information needed to use VASOSTRICT safely and effectively. See full prescribing information for VASOSTRICT. VASOSTRICT (vasopressin injection) for intravenous useVASOSTRICT (vasopressin in dextrose injection) for intravenous useInitial U.S. Approval: 2014
b1147beb-743e-4c62-8927-91192447f8b8
HUMAN PRESCRIPTION DRUG LABEL
Nov 16, 2023
Par Pharmaceutical, Inc.
DUNS: 092733690
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Vasopressin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Vasopressin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Vasopressin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Vasopressin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (7)
Vasopressin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
Vasopressin
Product Details
FDA regulatory identification and product classification information